Enalapril Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comprehensive analyses of the microRNA –messenger RNA–transcription factor regulatory network in mouse and human renal fibrosis
Conclusion: Pax2, Pax5, Sp1, Sp2, Sp3, and Sp4 together with Bckdha-dependent miR-125a-3p/Vegfa-dependent miR-199a-5p formed a co-regulatory network enabling Bckdha/Vegfa to be tightly controlled in the underlying pathogenesis of RF across mice and humans. Vegfa could act as a potential novel diagnostic marker and might be targeted by enalapril for RF therapy. (Source: Frontiers in Genetics)
Source: Frontiers in Genetics - November 15, 2022 Category: Genetics & Stem Cells Source Type: research

Triosephosphate-Isomerase Deficiency: Epiphenomenon or Cause of Loin Pain Haematuria Syndrome?
A 32-year-old male patient presented the clinical picture of loin pain haematuria syndrome with pain attacks accompanied by macrohaematuria. In renal biopsy, the preglomerular vessels showed segmental wall hyalinosis in the sense of low-grade nephrosclerosis, and glomerular capillaries with slightly but diffusely thickened, non-split basal membranes on electron microscopy. Notable were irregularly deformed, different dense erythrocytes in the glomerular capillaries, and several tubular lumina. The suspicion of erythrocytic enzyme deficiency could be confirmed. The enzyme activities of the erythrocytes were predominantly no...
Source: Case Reports in Nephrology and Dialysis - November 11, 2022 Category: Urology & Nephrology Source Type: research

IJERPH, Vol. 19, Pages 14375: The Correlation between Two Angiotensin-Converting Enzyme Inhibitor & rsquo;s Concentrations and Cognition
IJERPH, Vol. 19, Pages 14375: The Correlation between Two Angiotensin-Converting Enzyme Inhibitor’s Concentrations and Cognition International Journal of Environmental Research and Public Health doi: 10.3390/ijerph192114375 Authors: Attila Nagy Réka Májer Enikő Csikai Adrienn Dobos Gábor Süvegh László Csiba Both lisinopril and enalapril are angiotensin-converting enzyme (ACE) drugs and widely used in the treatment of hypertension. Enalapril does not cross the blood&ndash;brain barrier, but lisinopril is centrally active. Our goal was to find out if there was a link between the act...
Source: International Journal of Environmental Research and Public Health - November 3, 2022 Category: Environmental Health Authors: Attila Nagy R éka Májer Enik ő Csikai Adrienn Dobos G ábor Süvegh L ászló Csiba Tags: Article Source Type: research

Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril
CONCLUSIONS: Lercanidipine may be regarded as an ideal antihypertensive drug for patients at renal risk and possibly the preferred choice among calcium channel blocker drugs.PMID:36314318 | DOI:10.26355/eurrev_202210_30018 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - October 31, 2022 Category: Drugs & Pharmacology Authors: N Ferri A Corsini R Pontremoli Source Type: research

Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril
CONCLUSIONS: Lercanidipine may be regarded as an ideal antihypertensive drug for patients at renal risk and possibly the preferred choice among calcium channel blocker drugs.PMID:36314318 | DOI:10.26355/eurrev_202210_30018 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - October 31, 2022 Category: Drugs & Pharmacology Authors: N Ferri A Corsini R Pontremoli Source Type: research